Canada's Common Drug Review: a positive effect on drug coverage?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.643, 2011-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Common Drug Review Recommendations: An Evidence Base for Expectations?

By Rocchi Angela Miller Elizabeth Hopkins Robert B. Goeree Ron

PharmacoEconomics, Vol. 30, Iss. 3, 2012-03 ,pp. : 229-246

Adis International

Access to resources Recommend Favorite

Common drug review aids drug coverage decisions

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 510, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Reference-based drug pricing in Canada in need of fine-tuning?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Factors affecting negative Common Drug Review recommendations in Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Risperidone drug monitoring beneficial?

Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite